Tacrolimus is an immunosuppressant drug that is primarily used to prevent organ rejection in patients who have undergone a transplant surgery. It works by suppressing the immune system, which helps to prevent the body from rejecting the transplanted organ. Tacrolimus is available in various forms such as capsules, tablets, ointment, and injection. The global Tacrolimus Market is expected to grow significantly in the coming years due to the increasing number of organ transplant surgeries and the rising prevalence of autoimmune diseases. The global tacrolimus market is estimated to be valued at US$ 6,485.3 million in 2022 and is expected to exhibit a CAGR of 4.7% during the forecast period (2022-2030).
Read More- https://cmi-latestreportorientedblogs.blogspot.com/2023/04/the-global-tacrolimus-market-is.html
